FIELD: medicine.
SUBSTANCE: significant criteria are determined: stage of TNM disease (I-IV), metastatic damage of regional lymph nodes, presence of distant metastatic lesions, lesion of the portal vein trunk and branches, presence of ascites. The resulting data are scored. Based on the scores obtained, the probability of peritoneal carcinomatosis in patients with portal cholangiocarcinoma is determined.
EFFECT: method allows to accurately determine the probability of peritoneal carcinomatosis and to evaluate tumor resectability by evaluating the most significant criteria.
4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING SURVIVAL IN PATIENTS WITH PORTAL CHOLANGIOCARCINOMA AFTER SURGICAL TREATMENT | 2017 |
|
RU2653810C1 |
| METHOD FOR DETERMINING SURVIVAL IN PATIENTS WITH PROXIMAL BILE DUCT TUMORS DURING PREOPERATIVE STAGE | 2018 |
|
RU2678472C1 |
| A METHOD FOR PREDICTING GENERAL SURVIVABILITY IN PATIENTS WITH A CLOTHKIN TUMOR AFTER SURGICAL TREATMENT | 2016 |
|
RU2617183C1 |
| METHOD FOR THE TREATMENT OF UNRESECTABLE HYLUS CHOLANGIOCARCINOMA | 2020 |
|
RU2755329C2 |
| METHOD OF DETERMINATION OF SURVIVAL IN PATIENTS WITH PORTAL CHOLANGIOCARCINOMA | 2018 |
|
RU2666208C1 |
| METHOD FOR DETERMINING SURVIVAL OF PATIENTS WITH INTRAHEPAPER CHOLANGIOCELLULAR CANCER IN THE POSTOPERATIVE PERIOD | 2021 |
|
RU2773252C1 |
| METHOD OF PARENCHYMA-PRESERVING RIGHT-SIDED EXPANDED HEMIHEPATECTOMY | 2017 |
|
RU2653637C1 |
| METHOD FOR PHOTODYNAMIC THERAPY IN THE TREATMENT OF UNRESECTABLE ADENOCARCINOMA OF EXTRAHEPATIC BILE DUCTS | 2020 |
|
RU2753402C1 |
| METHOD OF COMBINED TREATMENT OF UNRESECTABLE CANCER OF EXTRAHEPINOUS BILE DUCTS | 2018 |
|
RU2703330C2 |
| SURGICAL METHOD FOR TREATING HEPATIC HILUS CHOLANGIOCARCINOMA CASES | 2006 |
|
RU2314044C1 |
